AMERIPRISE FINANCIAL INC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$1,289,000
+17.4%
314,024
+2.1%
0.00%
Q4 2021$1,098,000
+1191.8%
307,567
+1224.5%
0.00%
Q3 2021$85,000
+2.4%
23,221
+21.9%
0.00%
Q2 2021$83,000
+69.4%
19,054
+58.8%
0.00%
Q1 2021$49,000
+2.1%
12,0000.0%0.00%
Q4 2020$48,000
+23.1%
12,000
-17.2%
0.00%
Q3 2020$39,000
+3800.0%
14,500
+4042.9%
0.00%
Q3 2014$1,000
-66.7%
350
-73.2%
0.00%
Q2 2014$3,000
-89.7%
1,305
-81.4%
0.00%
Q3 2013$29,0000.0%7,0270.0%0.00%
Q2 2013$29,0007,0270.00%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders